© Frontline Medical Communications 2018-2021. Reprinted with permission, all rights reserved.
Converge Coverage
Uptake of new heart failure drugs slow despite guidelines
EXPERT ANALYSIS FROM THE CARDIOVASCULAR CONFERENCE AT SNOWMASS
Related Articles
Early Versus Later Anticoagulation for Stroke with Atrial Fibrillation
April 5, 2017
Mr. Gegg-Mitchell Clinical question: What is the safety and efficacy of early compared with later initiation of direct oral anticoagulants (DOACs) in patients with atrial fibrillation and...
The STRONG-HF Trial: Evaluating the Safety, Tolerability, and Effectiveness of Up-titrating GDMT in Acute Heart Failure
April 5, 2017
Clinical question: Does rapid up-titration of guideline-directed medical therapies (GDMT) following admission for acute heart failure improve patient outcomes? Background: GDMT provides...
Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes
April 5, 2017
Clinical question: Is the treatment strategy with ticagrelor superior to prasugrel in acute coronary syndrome (ACS) with planned invasive evaluation at one year? Background: Dual antiplatelet...
Syncope: Things We Do for No Reason & Things We Do for Reason
April 5, 2017
Syncope is broadly classified into reflex-mediated (60% to 70%), orthostatic (10%), and cardiac (10% to 20%). Cerebrovascular causes were removed from American and European guidelines (or listed as a...